DUBOWCHIK; Gene M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for DUBOWCHIK; Gene M..The latest application filed is for "formulation for oral delivery of proteins, peptides and small molecules with poor permeability".
Company Profile
7.27.30
- DUBOWCHIK; Gene M. - New Haven CT
- Dubowchik; Gene M. - Middlefield CT
- Dubowchik; Gene M. - Middlefleid CT
Patent Activity
| Patent | Date |
|---|---|
| Formulation For Oral Delivery Of Proteins, Peptides And Small Molecules With Poor Permeability App 20220249468 - PLASSAT; Vincent ; et al. | 2022-08-11 |
| Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20220211812 - Dubowchik; Gene M. ; et al. | 2022-07-07 |
| Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof Grant 11,364,281 - Dubowchik , et al. June 21, 2 | 2022-06-21 |
| Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof Grant 11,224,634 - Dubowchik , et al. January 18, 2 | 2022-01-18 |
| Prodrugs Of Cgrp Antagonists App 20210395223 - Conway; Charles M. ; et al. | 2021-12-23 |
| Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides Grant 11,185,570 - Dubowchik , et al. November 30, 2 | 2021-11-30 |
| Pyrimidine carboxamides as GSK-3 inhibitors Grant 11,053,258 - Luo , et al. July 6, 2 | 2021-07-06 |
| Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20210196791 - Dubowchik; Gene M. ; et al. | 2021-07-01 |
| GSK-3 inhibitors Grant 10,774,086 - Hartz , et al. Sept | 2020-09-15 |
| GSK-3 inhibitors Grant 10,752,609 - Hartz , et al. A | 2020-08-25 |
| Pyrimidine Carboxamides As Gsk-3 Inhibitors App 20200181170 - Luo; Guanglin ; et al. | 2020-06-11 |
| Gsk-3 Inhibitors App 20190315714 - Hartz; Richard A. ; et al. | 2019-10-17 |
| Gsk-3 Inhibitors App 20190276463 - Hartz; Richard A. ; et al. | 2019-09-12 |
| Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20190256570 - Dubowchik; Gene M. ; et al. | 2019-08-22 |
| Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof Grant 10,266,578 - Dubowchik , et al. | 2019-04-23 |
| Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof App 20180222960 - DUBOWCHIK; Gene M. ; et al. | 2018-08-09 |
| GSK-3 inhibitors Grant 9,718,804 - Luo , et al. August 1, 2 | 2017-08-01 |
| Substituted Pyridine Derivatives Useful as GSK-3 Inhibitors App 20160289210 - Luo; Guanglin ; et al. | 2016-10-06 |
| Gsk-3 Inhibitors App 20160272621 - Luo; Guanglin ; et al. | 2016-09-22 |
| CGRP receptor antagonists Grant 8,748,429 - Luo , et al. June 10, 2 | 2014-06-10 |
| CGRP receptor antagonist Grant 8,481,546 - Chaturvedula , et al. July 9, 2 | 2013-07-09 |
| CGRP Receptor Antagonists App 20130096130 - Luo; Guanglin ; et al. | 2013-04-18 |
| CGRP Receptor Antagonists App 20130053570 - Luo; Guanglin ; et al. | 2013-02-28 |
| CGRP receptor antagonists Grant 8,314,117 - Luo , et al. November 20, 2 | 2012-11-20 |
| CGRP Receptor Antagonist App 20120059017 - Chaturvedula; Prasad V. ; et al. | 2012-03-08 |
| CGRP Receptor Antagonists App 20110251223 - Luo; Guanglin ; et al. | 2011-10-13 |
| Anti-migraine spirocycles Grant 7,842,808 - Chaturvedula , et al. November 30, 2 | 2010-11-30 |
| Therapeutic agents for the treatment of migraine Grant 7,772,244 - Degnan , et al. August 10, 2 | 2010-08-10 |
| Spirocyclic anti-migraine compounds Grant 7,754,732 - Chaturvedula , et al. July 13, 2 | 2010-07-13 |
| Heterocyclic anti-migraine agents Grant 7,569,578 - Luo , et al. August 4, 2 | 2009-08-04 |
| Constrained compounds as CGRP-receptor antagonists Grant 7,470,680 - Chaturvedula , et al. December 30, 2 | 2008-12-30 |
| Anti-migraine treatments Grant 7,314,883 - Chen , et al. January 1, 2 | 2008-01-01 |
| Constrained Compounds As Cgrp-receptor Antagonists App 20070259851 - Chaturvedula; Prasad V. ; et al. | 2007-11-08 |
| Anti-migraine Treatments App 20070232600 - Chen; Ling ; et al. | 2007-10-04 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors Grant 7,244,746 - Han , et al. July 17, 2 | 2007-07-17 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors Grant 7,238,699 - Vrudhula , et al. July 3, 2 | 2007-07-03 |
| Spirocyclic Anti-migraine Compounds App 20070149502 - Chaturvedula; Prasad V. ; et al. | 2007-06-28 |
| Anti-migraine Spirocycles App 20070149503 - CHATURVEDULA; PRASAD V. ; et al. | 2007-06-28 |
| Calcitonin gene related peptide receptor antagonists Grant 7,220,862 - Chaturvedula , et al. May 22, 2 | 2007-05-22 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors Grant 7,125,990 - Han , et al. October 24, 2 | 2006-10-24 |
| Novel therapeutic agents for the treatment of migraine App 20050215576 - Degnan, Andrew P. ; et al. | 2005-09-29 |
| Heterocyclic anti-migraine agents App 20050153959 - Luo, Guanglin ; et al. | 2005-07-14 |
| Tetrahydroisoquinoline derivatives as melatonin MT2 antagonists Grant 6,908,931 - Dubowchik , et al. June 21, 2 | 2005-06-21 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors Grant 6,888,004 - Dubowchik , et al. May 3, 2 | 2005-05-03 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors App 20040235924 - Han, Xiaojun ; et al. | 2004-11-25 |
| Tetrahydroisoquinoline derivatives as melatonin MT2 antagonists App 20040235891 - Dubowchik, Gene M. ; et al. | 2004-11-25 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors App 20040225001 - Vrudhula, Vivekananda M. ; et al. | 2004-11-11 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors App 20040225130 - Han, Xiaojun ; et al. | 2004-11-11 |
| Calcitonin gene related peptide receptor antagonists App 20040204397 - Chaturvedula, Prasad V. ; et al. | 2004-10-14 |
| Branched peptide linkers Grant 6,759,509 - King , et al. July 6, 2 | 2004-07-06 |
| Calcitonin gene related peptide receptor antagonists App 20040063735 - Chaturvedula, Prasad V. ; et al. | 2004-04-01 |
| Imidazolyl derivatives as corticotropin releasing factor inhibitors App 20020183375 - Dubowchik, Gene M. ; et al. | 2002-12-05 |
| Substituted azole derivatives as inhibitors of corticotropin releasing factor App 20020161019 - Dubowchik, Gene M. ; et al. | 2002-10-31 |
| Neurotrophic difluoroamide agents Grant 6,096,762 - Vrudhula , et al. August 1, 2 | 2000-08-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 